טוען...
Eltrombopag use for refractory immune thrombocytopenia in pregnancy: A case report
BACKGROUND: Immune thrombocytopenic purpura (ITP) is a rare autoimmune disorder that involves platelet destruction in the spleen. Eltrombopag (Promacta®), a thrombopoietin agonist, has been used in non-pregnant patients to manage ITP, but few cases of its use in pregnancy have been reported. CASE PR...
שמור ב:
| הוצא לאור ב: | Case Rep Womens Health |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7788087/ https://ncbi.nlm.nih.gov/pubmed/33437657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.crwh.2020.e00281 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|